ENTA – enanta pharmaceuticals, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ENTA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/14

08:09 am

enta

Enanta Pharmaceuticals (NASDAQ:ENTA) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $17.00 price target on the stock.

Low Report

Enanta Pharmaceuticals (NASDAQ:ENTA) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $17.00 price target on the stock.

Report

11/14

07:26 am

enta

Rating for ENTA

Medium Report

Rating for ENTA

Report

11/14

04:53 am

enta

Enanta initiated with an Overweight at JPMorgan

Low Report

Enanta initiated with an Overweight at JPMorgan

Report

10/1

12:25 pm

enta

Rating for ENTA

Low Report

Rating for ENTA

Report

10/1

12:25 pm

enta

Rating for ENTA

Low Report

Rating for ENTA

Report

10/1

10:21 am

enta

Enanta upgraded to Buy from Hold at Jefferies

Medium Report

Enanta upgraded to Buy from Hold at Jefferies

Report

10/1

10:21 am

enta

Enanta upgraded to Buy from Hold at Jefferies

Medium Report

Enanta upgraded to Buy from Hold at Jefferies

Report

9/15

09:48 am

enta

Rating for ENTA

Medium Report

Rating for ENTA

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.